Circulating tumor cells (CTCs) harvested using the Parsortix® system, reveal a gene expression profile associated with development and progression of brain metastasis in melanoma.
Latest report
Annual Report December 2023
Please click the links below to download our Annual and Interim Reports and Financial Statements
Open PDFFor any investor relations queries please contact
investor@angleplc.comFor any investor relations queries please contact
investor@angleplc.comCirculating tumor cells (CTCs) harvested using the Parsortix® system, reveal a gene expression profile associated with development and progression of brain metastasis in melanoma.